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AbstrAct
Introduction Patients with symptomatic 
spondylolisthesis are frequently treated with nerve 
root decompression, in addition to pedicle screw 
fixation and interbody fusion. Minimally invasive 
approaches are gaining attention in recent years, 
although there is no clear evidence supporting the 
proclamation of minimally invasive spine surgery 
(MISS) being better than open surgery. We present the 
design of the MISOS (Minimal Invasive Surgery versus 
Open Surgery) trial on the effectiveness of MISS 
versus open surgery in patients with degenerative or 
spondylolytic spondylolisthesis.
Methods and analysis All patients (age 18–75 years) 
with neurogenic claudication or radicular leg pain 
based on low-grade degenerative or spondylolytic 
spondylolisthesis with persistent complaints for 
at least 3 months are eligible. Patients will be 
randomised into mini-open decompression with 
bilateral interbody fusion with percutaneous pedicle 
screw fixation (MISS), or conventional surgery with 
decompression and instrumented fusion with pedicle 
screws and bilateral interbody fusion (open). The 
primary outcome measure is Visual Analogue Scale 
of self-reported low back pain. Secondary outcome 
measures include improvement of leg pain, Oswestry 
Disability Index, patients’ perceived recovery, quality 
of life, resumption of work, complications, blood loss, 
length of hospital stay, incidence of reoperations and 
documentation of fusion. This study is designed as a 
multicentre, randomised controlled trial in which two 
surgical techniques are compared in a parallel group 
design. Based on a 20 mm difference of low back pain 
score at 6 weeks (power of 90%, assuming 8% loss to 
follow-up), a total of 184 patients will be needed. All 
analyses will be performed according to the intention-
to-treat principle.
Ethics and dissemination The study has been 
approved by the Medical Ethical Review Board 
Southwest Holland in August 2014 (registration number 
NL 49044.098.14) and subsequently approved by the 
board of all participating hospitals. Dissemination will 
include peer-reviewed publications and presentations at 
national and international conferences.
trial registration number NTR 4532, pre-results.
IntroductIon
background and rationale
Patients with degenerative or spondylolytic 
spondylolisthesis of the lumbar spine usually 
present with radicular leg pain or neuro-
genic claudication, with or without low back 
pain. Whenever conservative management 
fails, patients are offered surgery. In case 
of stable spondylolisthesis documented on 
dynamic radiographs, patients can be treated 
with decompression alone, and the modest 
difference in favour of additional instrumen-
tation does not justify the associated higher 
costs for implants and longer duration of 
surgery.1 In case of unstable spondylolisthesis, 
most patients will be treated with nerve root 
decompression in addition to pedicle screw 
fixation and interbody fusion. However, this 
surgical approach usually implies large skin 
incisions with detachment of the paraverte-
bral muscles, which may result in disabling 
postoperative low back pain and higher 
complications with consequent longer reha-
bilitation period.2
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Protocol
strengths and limitations of this study
 ► The Minimal Invasive Surgery versus Open 
Surgery (MISOS) trial evaluates the effectiveness 
of percutaneous pedicle screw fixation versus 
open surgery in patients with degenerative or 
spondylolytic spondylolisthesis.
 ► The trial is the largest, multicentre, randomised trial 
on minimal invasive surgery versus open surgery in 
patients with spondylolisthesis.
 ► Methodological strengths include appropriate 
sample size calculation based on difference in early 
postoperative low back pain.
 ► It is not feasible to blind the patients for the allocated 
treatment.
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box Inclusion and exclusion criteria
Inclusion criteria
 ► Age between 18 and 75 years
 ► Neurogenic claudication or radicular leg pain with or without low 
back pain
 ► Degenerative or spondylolytic spondylolisthesis grade I or II with 
spinal stenosis
 ► Persistent complaints for at least 3 months, regardless of 
conservative treatments
 ► Be able to understand the Dutch language and comprehend the 
questionnaires and patient information
 ► Written informed consent given
Exclusion criteria
 ► Previous spine fusion surgery at the same level
 ► Osteoporosis
 ► Active infection or prior infection at the surgical site
 ► Active cancer
 ► Spondylolisthesis greater than grade III
 ► More than one symptomatic level that needs fusion
 ► Pregnancy
 ► Contraindication for surgery
 ► Severe mental or psychiatric disorder
 ► Alcoholism
 ► Inadequate knowledge of Dutch language
 ► Morbid obesity (body mass index >40)
Worldwide, minimally invasive spine surgery (MISS) is 
becoming more and more popular. The rationale behind 
minimally invasive techniques is less tissue damage, 
reduced back pain leading to a shorter rehabilitation 
period, and faster return to work and resumption of 
daily activities.3 Despite numerous studies on minimally 
invasive lumbar fusion techniques, level 1 evidence on 
outcome of MISS versus open surgery is scarce. There 
is no evidence supporting the proclamation of small 
(minimally invasive) being better. There is only one 
randomised controlled trial, of low quality, on minimally 
invasive lumbar fusion, performed by Wang et al.4 They 
reported 41 cases who underwent minimally invasive 
transforaminal lumbar fusion versus 38 patients who 
underwent open surgery. There was no difference in pain 
between both groups during the follow-up of 2 years, 
although the Oswestry Disability Index (ODI) score in 
patients treated with MISS was significantly better during 
the first 12 months. This difference, however, diminished 
over time.
Recently, two reviews on minimally invasive fusion 
versus open surgery have been published,5 6 and one 
review specifically focused on spondylolisthesis.7 Overall, 
MISS was associated with less blood loss and shorter 
hospitalisation, and there was no difference in terms of 
outcome, fusion rates and complications. However, the 
results should be interpreted carefully since the included 
studies displayed heterogeneous patient populations and 
neither review contained a level 1 randomised controlled 
trial.
In the MISOS (Minimal Invasive Surgery versus Open 
Surgery) trial, patients with degenerative or spondylo-
lytic spondylolisthesis will be randomised into mini-open 
decompression with bilateral interbody fusion with percu-
taneous pedicle screw fixation (MISS), or conventional 
open surgery with decompression and instrumented 
fusion with pedicle screws and bilateral interbody fusion 
(open). We hypothesise that patients treated with MISS 
have a faster speed of recovery with less low back pain at 
2 weeks and 6 weeks after surgery, and similar outcome 
at 1 year after surgery, as compared with patients treated 
with open surgery. We will especially focus on the short-
term results because that is the period in which possible 
differences in speed of recovery may become clear in 
case of less invasive techniques. The presented protocol 
follows the recommendations outlined in the Standard 
Protocol Items Recommendations for Interventional 
Trials (SPIRIT) guidelines for randomised controlled 
trials.
research aim and objectives
Despite numerous studies on minimally invasive lumbar 
fusion techniques, level 1 evidence on outcome of MISS 
versus open surgery is scarce. The objective of our trial 
is to determine whether minimally invasive lumbar 
fusion will result in faster recovery and less low back pain 
compared with conventional open surgery in patients 
with degenerative or spondylolytic spondylolisthesis. The 
primary outcome measure is short-term low back pain at 
2 weeks and 6 weeks.
MEthods And AnAlysIs
study design and settings
This study is designed as a multicentre, randomised 
controlled trial in which patients with symptomatic spon-
dylolisthesis (degenerative or spondylolytic) will be allo-
cated into minimally invasive pedicle screw fixation versus 
open surgery. In order to recruit enough patients, the 
study will be performed in three neurosurgical centres 
in the Netherlands: Medical Center Haaglanden in The 
Hague, Haga Hospital in The Hague, and University 
Medical Center Groningen, Groningen.
Patient selection
All patients (age between 18 and 75 years) with neuro-
genic claudication or radicular leg pain based on 
low-grade (Meyerding grades I and II) degenerative or 
spondylolytic spondylolisthesis with persistent complaints 
for at least 3 months are eligible for the study. Additional 
inclusion and exclusion criteria are shown in the box.
randomisation
Randomisation will be computer-generated and will be 
performed prior to surgery at the outpatient clinic. A 
predefined block size will be used to ensure balanced 
group sizes at the end of the inclusion period. When 
surgery is rescheduled the patient stays in the same rando-
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of surgery is documented. Blinding is not feasible because 
of differences in surgical wounds.
surgical intervention
All patients in both groups will be operated with the aid of 
spinal navigation (O-arm (Medtronic) or 3D-Orbic C-arm 
(Siemens)) and will be positioned on a radiolucent spine 
table. In case of the standard open procedure, a long 
midline skin incision (10–15 cm) is made, after which 
the paravertebral muscles are detached from the midline 
and retracted laterally in order to expose the facet joints 
and pedicle entry point. After the pedicle screws are posi-
tioned, the disc will be removed bilaterally and packed 
with autogenous bone chips, followed by bilateral place-
ment of polyetheretherketone (PEEK) posterior lumbar 
interbody fusion (PLIF) cages. In case of the minimally 
invasive surgery, a small midline incision (3–5 cm) will be 
made to perform mini-open decompression and place-
ment of bilateral PEEK PLIF cages. In addition, two small 
paramedian incisions will be made on both sides for 
percutaneous pedicle screw fixation.
All participating surgeons have performed at least 20 
procedures of MISS prior to the start of the trial.
outcome measurements
Primary outcome
The primary outcome is the score on the Visual Analogue 
Scale (VAS) of low back pain (ranging from 0 to 100 mm) 
in the short term (2 weeks and 6 weeks after surgery). 
Pain will be assessed on a horizontal 100 mm scale varying 
from 0 mm, ‘no pain’, to 100 mm, ‘the worst pain imagin-
able’. Patients do not see the results of earlier assessments 
and will score the pain experienced at the visit. Reliability, 
validity and responsiveness of VAS have been shown.8 The 
minimal clinically important difference of the VAS for 
pain is 20 mm.9
Secondary outcome
Several secondary outcome measures will be documented.
Oswestry Disability index
The ODI is one of the principal condition-specific outcome 
measures used in the management of spinal disorders.10 
In this study we will use the current version 2.1a. The ODI 
is the most commonly used outcome measures in patients 
with low back pain. It has been extensively tested, showed 
good psychometric properties and is applicable in a wide 
variety of settings. There are 10 questions (items), each 
with six possible answers, and each answer option receives 
a score of 0–5 points, yielding a score range between 0 
and 50, which is scaled to a 100% range. The questions 
are designed in a way to realise how the back or leg pain 
is affecting the patient’s ability to manage in everyday life.
Patients’ perceived recovery
This is a 7-point Likert scale measuring the perceived 
recovery, varying from ‘complete recovery’ to ‘worse 
than ever’. This outcome scale has been used in 
previous studies and is regarded valid and responsive 
to change.11 ‘Complete recovery’ and ‘almost complete 
recovery’ will be defined as good outcome (Likert 1 and 
2).
Neurological outcome
All patients will be examined neurologically at 3 months’ 
follow-up.
VAS of leg pain
This parameter will measure the experienced pain 
intensity in the leg during the week before visiting the 
researcher. Pain will be assessed on a horizontal 100 mm 
scale, varying from 0 mm, ‘no pain’, to 100 mm, ‘the worst 
pain imaginable’. Patients do not see the results of earlier 
assessments and will score the pain experienced at the 
visit. Reliability, validity and responsiveness of VAS have 
been shown.8
Quality of life (EQ-5D)
The EuroQol (EQ-5D) measures five dimensions 
(mobility, self-care, daily activities, pain/discomfort, 
anxiety/depression) on a 3-point scale (no, some or 
extreme problems). For each health state described by 
the patients, a utility score can be calculated that reflects 
society’s valuation of that health state. The Dutch tariff 
for the EQ-5D will be used.12 Whereas the EQ-5D provides 
society’s assessment of patients’ health, the patients them-
selves will also assess their own health on VAS, ranging 
from 0.0 (as bad as death) to 1.0 (optimal health). Both 
the EQ-5D and the VAS will be reported in questionnaires 
filled out at home.
Resumption of work
Hypothetically, MISS may result in faster recovery and 
earlier return to work. Therefore, patients will be asked 
on every follow-up moment whether they have resumed 
their work activities.
The following are other outcome measures that will be 
documented:
Incidence of reoperations
In general, reoperation is considered as bad outcome and 
therefore used as an outcome measure. The incidence of 
reoperation in both groups will be measured.
Complications
A systematic assessment of complications (including 
wound infection, deep venous thrombosis, urine tract 
infection, haematoma and progressive neurological 
deficit) will be carried out by the surgeon. Moreover, 
surgeons will be asked for perioperative complications 
like cerebrospinal fluid leakage, nerve root damage 
and exploration on the wrong disc level. During the 
complete course of the study, all adverse events will be 
reported.
Surgical parameters
Blood loss, time of surgery and length of hospital stay will 
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For the assessment of fusion we will use conventional 
dynamic X-ray. The flexion–extension plane images will 
be analysed and quantified using FXA (Functional X-Ray 
Analysis). The software allowed measurement of rota-
tion on flexion–extension films with an accuracy of ±1°. 
Absence of range of motion of the index disc level will be 
documented as indicator of fusion. We defined fusion as 
rotation ≤2° and ≤1.25 mm translation on flexion–exten-
sion film.13
Correction of spondylolisthesis
Based on the preoperative and postoperative X-rays, 
we will analyse the correction of spondylolisthesis in all 
patients.
sample size
The sample size calculation is based on a difference in low 
back pain score of 20 mm at 6 weeks after surgery (60 mm 
for open surgery vs 40 mm for minimally invasive surgery. 
Assuming an SD of 40 mm, 85 patients will be needed 
in both groups (alpha=0.05; beta=0.10). Including 8% 
loss to follow-up, a total of 184 patients will need to be 
randomised.
data collection, management and analysis
All patients will be analysed preoperatively, as well as 
2 weeks, 6 weeks, 3 months, 6 months, 12 months and 
24 months postoperatively, according to the assessment 
schedule in table 1.
The data from initial visits, hospitalisation and follow-up 
visits will be entered into a database via an electronic data 
capture system (Castor EDC). The data will be recorded 
and analysed without any personal identifiers by using 
coded information. The source documents and identi-
fiers will be archived in a security facility and permission 
for accessing data will be documented per investigator.
All analyses will be performed according to the inten-
tion-to-treat principle. Differences between groups at 
baseline will be assessed by comparing means, medians 
or percentages, depending on the type of variable. The 
outcomes for function (ODI) and pain (VAS) will be anal-
ysed with a repeated-measures analysis of variance using 
a first-order autoregressive covariance matrix. The esti-
mated consecutive scores will be expressed as means and 
95% CIs. Kaplan-Meier survival analysis will be used to esti-
mate time elapsed between randomisation and recovery, 
and curves will be compared using the log-rank test. A 
Cox model will be used to compare rates of recovery by 
calculation of an HR. The level of significance will be 
p<0.05.
safety monitoring and adverse events
The study will be monitored by the Trial Coordinator 
Center of Haaglanden Medical Center. At least one moni-
toring visit per year per centre will be conducted. During 
the complete study period, all adverse events will be 








pen: first published as 10.1136/bmjopen-2017-017882 on 12 November 2017. Downloaded from 
 5Arts MP, et al. BMJ Open 2017;7:e017882. doi:10.1136/bmjopen-2017-017882
Open Access
experience occurring to a participant, whether or not 
related to the intervention.
EthIcs And dIssEMInAtIon
Recently, three reviews on minimally invasive spondylod-
esis versus open spondylodesis have been published, of 
which one review specifically on spondylolisthesis.5–7 The 
clinical outcome, fusion rates and complication rates 
are comparable between minimally invasive interbody 
fusion surgery and open fusion surgery, although MISS 
is associated with reduced blood loss and shorter hospital 
stay. However, these results should be interpreted care-
fully since the included studies displayed heterogeneous 
patient populations and neither review contained a level 
1 randomised controlled trial. This lack of evidence was 
the basis of the MISOS trial. The objective of our trial is to 
determine whether minimally invasive lumbar fusion will 
result in faster recovery and less low back pain compared 
with conventional open surgery. We plan to disseminate 
our findings through presentations at national and inter-
national spine conferences, and we will submit findings 
for publication in peer-reviewed international journals. 
Recruitment of patients has started in September 2015 
and will be finished when all 184 patients have been 
followed up for 2 years, which is expected at the end of 
2019.
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